Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2018, Article ID 7351902, 7 pages
https://doi.org/10.1155/2018/7351902
Research Article

Elevated and Correlated Expressions of miR-24, miR-30d, miR-146a, and SFRP-4 in Human Abdominal Adipose Tissue Play a Role in Adiposity and Insulin Resistance

1Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA
2University of Central Florida College of Medicine, Orlando, FL, USA
3Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL, USA
4The Chemical Engineering Department, Massachusetts Institute of Technology, Cambridge, MA, USA

Correspondence should be addressed to Attila A. Seyhan; moc.oohay@nahyes_alitta

Received 14 October 2017; Accepted 6 December 2017; Published 12 March 2018

Academic Editor: Guido Sebastiani

Copyright © 2018 Yury O. Nunez Lopez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. W. Haslam and W. P. T. James, “Obesity,” The Lancet, vol. 366, no. 9492, pp. 1197–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Sun, C. M. Kusminski, and P. E. Scherer, “Adipose tissue remodeling and obesity,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2094–2101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Weyer, J. E. Foley, C. Bogardus, P. A. Tataranni, and R. E. Pratley, “Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance,” Diabetologia, vol. 43, no. 12, pp. 1498–1506, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Pasarica, J. Rood, E. Ravussin, J. M. Schwarz, S. R. Smith, and L. M. Redman, “Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 8, pp. 4052–4055, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Pasarica, O. R. Sereda, L. M. Redman et al., “Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response,” Diabetes, vol. 58, no. 3, pp. 718–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Pasarica, B. Gowronska-Kozak, D. Burk et al., “Adipose tissue collagen VI in obesity,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 12, pp. 5155–5162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. H. Goossens, A. Bizzarri, N. Venteclef et al., “Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation,” Circulation, vol. 124, no. 1, pp. 67–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. I. S. Wood, F. P. de Heredia, B. Wang, and P. Trayhurn, “Cellular hypoxia and adipose tissue dysfunction in obesity,” The Proceedings of the Nutrition Society, vol. 68, no. 04, pp. 370–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Ye, “Emerging role of adipose tissue hypoxia in obesity and insulin resistance,” International Journal of Obesity, vol. 33, no. 1, pp. 54–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Khan, E. S. Muise, P. Iyengar et al., “Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI,” Molecular and Cellular Biology, vol. 29, no. 6, pp. 1575–1591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Garufi, A. A. Seyhan, and M. Pasarica, “Elevated secreted frizzled-related protein 4 in obesity: a potential role in adipose tissue dysfunction,” Obesity, vol. 23, no. 1, pp. 24–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Muley, S. Majumder, G. K. Kolluru et al., “Secreted frizzled-related protein 4: an angiogenesis inhibitor,” The American Journal of Pathology, vol. 176, no. 3, pp. 1505–1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Mahdi, S. Hänzelmann, A. Salehi et al., “Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes,” Cell Metabolism, vol. 16, no. 5, pp. 625–633, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ehrlund, N. Mejhert, S. Lorente-Cebrián et al., “Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 3, pp. E503–E508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Pachori, M. Madan, Y. O. Nunez Lopez, F. Yi, C. Meyer, and A. A. Seyhan, “Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance,” Obesity, vol. 25, no. 4, pp. 697–703, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. O. Nunez Lopez, G. Garufi, and A. A. Seyhan, “Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes,” Molecular BioSystems, vol. 13, no. 1, pp. 106–121, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Ebert and P. A. Sharp, “Roles for microRNAs in conferring robustness to biological processes,” Cell, vol. 149, no. 3, pp. 515–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Seyhan, “MicroRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges,” Molecular BioSystems, vol. 11, no. 5, pp. 1217–1234, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Bonafe and F. Olivieri, “Circulating microRNAs in aging,” Oncotarget, vol. 6, no. 3, pp. 1340-1341, 2015. View at Publisher · View at Google Scholar
  20. T. J. Kirby and J. J. McCarthy, “MicroRNAs in skeletal muscle biology and exercise adaptation,” Free Radical Biology & Medicine, vol. 64, pp. 95–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Victoria, Y. O. Nunez Lopez, and M. M. Masternak, “MicroRNAs and the metabolic hallmarks of aging,” Molecular and Cellular Endocrinology, vol. 455, pp. 131–147, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Arner and A. Kulyte, “MicroRNA regulatory networks in human adipose tissue and obesity,” Nature Reviews Endocrinology, vol. 11, no. 5, pp. 276–288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Greenhill, “Non-coding RNA: exosomal microRNAs as novel adipokines,” Nature Reviews Genetics, vol. 18, no. 4, pp. 212–212, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Thomou, M. A. Mori, J. M. Dreyfuss et al., “Adipose-derived circulating miRNAs regulate gene expression in other tissues,” Nature, vol. 542, no. 7642, pp. 450–455, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Ying, M. Riopel, G. Bandyopadhyay et al., “Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity,” Cell, vol. 171, no. 2, pp. 372–384.e12, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. O. Nunez Lopez, A. G. Pittas, R. E. Pratley, and A. A. Seyhan, “Circulating levels of miR-7, miR-152 and miR-192 respond to vitamin D supplementation in adults with prediabetes and correlate with improvements in glycemic control,” The Journal of Nutritional Biochemistry, vol. 49, pp. 117–122, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. O. Nunez Lopez, P. M. Coen, B. H. Goodpaster, and A. A. Seyhan, “Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk,” International Journal of Obesity, vol. 41, no. 7, pp. 1121–1130, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Seyhan, Y. O. Nunez Lopez, H. Xie et al., “Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study,” Scientific Reports, vol. 6, no. 1, article 31479, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. C. L. Andersen, J. L. Jensen, and T. F. Ørntoft, “Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets,” Cancer Research, vol. 64, no. 15, pp. 5245–5250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Zhu, Q. Pan, X. Zhang et al., “MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression,” Carcinogenesis, vol. 34, no. 9, pp. 2071–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Lundgren, M. Svensson, S. Lindmark, F. Renström, T. Ruge, and J. W. Eriksson, “Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia',” Diabetologia, vol. 50, no. 3, pp. 625–633, 2007. View at Publisher · View at Google Scholar · View at Scopus